Oseltamivir Tamiflu Adult 75 mg PO BID X 5 d treatment 75 mgd PO for 7 d

Oseltamivir tamiflu adult 75 mg po bid x 5 d

This preview shows page 9 - 17 out of 46 pages.

Oseltamivir (Tamiflu)-Adult: 75 mg PO BID X 5 d (treatment), 75 mg/d PO for 7 d (prevention), Pediatric (1-12y) 30-75 mg BID PO for 5d (treatment), 30-75 mg/d for 7 d (prevention), TX & prevention of uncomplicated influenza for patient who is symptomatic for < 2 days; only antiviral agent effective in treatment of avian flu Nice to Know Peramivir (Rapivab) Ribavirin (Rebetron, Virazole)-Pregnancy category X Rimantadine (Flumadine) Zanamivir (Relenza)-Inhalation
Image of page 9
Copyright © 2017 Wolters Kluwer • All Rights Reserved Influenza A and Respiratory Antivirals Influenza A and Respiratory Antivirals Indications – Prevent shedding of the viral protein coat & entry of virus into cell Pharmacokinetics – Absorbed readily, excreted unchanged in the urine, metabolized in the urine and liver, feces and cellular level. Excreted primarily via urine but also feces. Contraindications – Allergy, renal impairment, pregnancy, or lactating Adverse Reactions – Dizziness, insomnia, nausea, orthostatic hypotension and urinary retention Drug-to-Drug Interactions Anticholinergic agents can lead to ꜛ Atropine like effects ASA & Tylenol -> decrease effect of these drugs
Image of page 10
Copyright © 2017 Wolters Kluwer • All Rights Reserved Nursing Considerations for Respiratory Antiviral Therapy Nursing Considerations for Respiratory Antiviral Therapy Pre Administration : History of allergy to antivirals, liver or renal dysfunction, Pregnancy or lactation Assessment-VS, orientation, reflexes, lung sounds Labs-renal/liver function Post Administration Assessment-VS, lung sounds, S&S of infection, Labs Safety- side rails up due to CNS symptoms, avoid driving & hazardous tasks if CNS effects occur, report any adverse effects Teaching-administer flu vaccines before season, take full course, regimen, dosing, AE, prevention of spreading
Image of page 11
Copyright © 2017 Wolters Kluwer • All Rights Reserved Prototype of Respiratory Antiviral Agents Prototype of Respiratory Antiviral Agents
Image of page 12
Copyright © 2017 Wolters Kluwer • All Rights Reserved Question Question Tell whether the following statement is true or false. Treatment of a viral infection is difficult without serious toxic effects for the host.
Image of page 13
Copyright © 2017 Wolters Kluwer • All Rights Reserved Answer Answer True Rationale: A virus must enter a human cell to survive, making it difficult to treat without serious toxic effects for the host.
Image of page 14
Copyright © 2017 Wolters Kluwer • All Rights Reserved Herpes Virus Herpes Virus Viruses account for a broad range of conditions, including cold sores, encephalitis, shingles, and genital infections. S&S Painful vesicles that often occur in clusters on skin, cornea, or mucous membranes. Usual course of primary disease is two weeks Duration of recurrences varies
Image of page 15
Copyright © 2017 Wolters Kluwer • All Rights Reserved Cytomegalovirus (CMV) Cytomegalovirus (CMV) May be asymptomatic Fatigue Nausea Jaundice If contracted during pregnancy can result in stillbirth, brain damage, or birth defects.
Image of page 16
Image of page 17

You've reached the end of your free preview.

Want to read all 46 pages?

  • Fall '17
  • Antiretroviral drug, Wolters Kluwer Health

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture